A
Alessandro Cucchetti
Researcher at University of Bologna
Publications - 328
Citations - 12149
Alessandro Cucchetti is an academic researcher from University of Bologna. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 56, co-authored 294 publications receiving 9748 citations. Previous affiliations of Alessandro Cucchetti include University of Genoa & Sapienza University of Rome.
Papers
More filters
Journal ArticleDOI
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
Rita Golfieri,Emanuela Giampalma,Matteo Renzulli,Roberto Cioni,Irene Bargellini,C. Bartolozzi,Andrea Doriguzzi Breatta,Giovanni Gandini,Roberto Nani,Daniele Gasparini,Alessandro Cucchetti,Luigi Bolondi,Franco Trevisani +12 more
TL;DR: The DEB-TACE and the cTACE are equally effective and safe, with the only advantage of DEB -TACE being less post-procedural abdominal pain.
Journal ArticleDOI
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma.
Vincenzo Mazzaferro,Carlo Sposito,Jian Zhou,Jian Zhou,Antonio Daniele Pinna,Luciano De Carlis,Jia Fan,Jia Fan,Matteo Cescon,Stefano Di Sandro,He Yi-feng,He Yi-feng,Andrea Lauterio,Marco Bongini,Alessandro Cucchetti +14 more
TL;DR: A model based on level of AFP, tumor size, and tumor number, to determine risk of death from HCC-related factors after liver transplantation is developed and might be used to select end points and refine selection criteria for liver transplants for patients with HCC.
Journal ArticleDOI
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection.
Anthony W.H. Chan,Jian-Hong Zhong,Sarah Berhane,Hidenori Toyoda,Alessandro Cucchetti,KeQing Shi,Toshifumi Tada,Charing C N Chong,Bang-De Xiang,Le-Qun Li,Paul B.S. Lai,Vincenzo Mazzaferro,Marta García-Fiñana,Masatoshi Kudo,Takashi Kumada,Sasan Roayaie,Philip J. Johnson +16 more
TL;DR: Large international study develops a statistical method that allows clinicians to estimate the risk of recurrence in an individual patient and shows that such models will be valuable in guiding surveillance follow-up and in the design of post-resection adjuvant therapy trials.
Journal ArticleDOI
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma
Alessandro Cucchetti,Fabio Piscaglia,Matteo Cescon,Antonio Colecchia,Giorgio Ercolani,Luigi Bolondi,Antonio Daniele Pinna +6 more
TL;DR: For very early HCC and in the presence of two or three nodules ≤3 cm, RFA is more cost-effective than resection; for single larger early stage HCCs, surgical resection remains the best strategy to adopt as a result of better survival rates at an acceptable increase in cost.
Journal ArticleDOI
Impact of model for end‐stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis
Alessandro Cucchetti,Giorgio Ercolani,Marco Vivarelli,Matteo Cescon,Matteo Ravaioli,Giuliano La Barba,Matteo Zanello,Gian Luca Grazi,Antonio Daniele Pinna +8 more
TL;DR: The MELD score can accurately predict postoperative liver failure and morbidity of cirrhotic patients referred for resection of HCC and should be used to select the best candidates for hepatectomy.